Sukhon Likitlersuang

This inventor holds 9 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignee: Allergan, Inc.. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sukhon Likitlersuang. Retrieved from https://idiyas.com/inventor/sukhon-likitlersuang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 15)

% Patents Active = 66.7

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Anaheim, CA (US) (2015)
Corona, CA (US) (2019)
Irvine, CA (US) (2015 - 2020)

Company Filing History:

9 out of 2,287

Allergan, Inc.

patents

Years Active: 2015-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10792288 - Preservative free brimonidine and timolol solutions (2020-10-06),

2. 10314887 - Two part formulation system for ophthalmic delivery (2019-06-11),

3. 10279005 - Stabilized omega-3 ophthalmic compositions (2019-05-07),

4. 10213431 - Preservative free brimonidine and timolol solutions (2019-02-26),

5. 10058560 - Preservative free bimatoprost and timolol solutions (2018-08-28),

6. 9763958 - Preservative free bimatoprost and timolol solutions (2017-09-19),

7. 9616017 - Two part formulation system for ophthalmic delivery (2017-04-11),

8. 9078854 - Preservative free bimatoprost and timolol solutions (2015-07-14),

9. 9061034 - Preservative free bimatoprost and timolol solutions (2015-06-23),

Title: Sukhon Likitlersuang: Innovator in Ophthalmic Solutions

Introduction

Sukhon Likitlersuang is a prominent inventor based in Irvine, CA, known for his contributions to ophthalmic solutions. With a total of 9 patents, he has made significant advancements in the field of eye care, particularly in the treatment of glaucoma.

Latest Patents

Among his latest patents, Sukhon has developed preservative-free brimonidine and timolol solutions. This invention is directed towards creating solutions that lower intra-ocular pressure and treat glaucoma without the use of preservatives. Another notable patent is a two-part formulation system for ophthalmic delivery. This innovation describes ophthalmic products and methods that include a stabilizing composition containing a therapeutically active agent, which is separated from a liquid vehicle composition by a barrier. The barrier can be removed to allow the two compositions to mix, resulting in an ophthalmically acceptable liquid.

Career Highlights

Sukhon Likitlersuang is currently employed at Allergan, Inc., where he continues to push the boundaries of ophthalmic research and development. His work has been instrumental in improving treatment options for patients suffering from eye conditions.

Collaborations

Sukhon collaborates with talented professionals in his field, including Chetan Pujara and Ajay P Parashar. These partnerships enhance the innovative processes and outcomes of their projects.

Conclusion

Sukhon Likitlersuang's contributions to ophthalmic solutions exemplify the impact of innovation in healthcare. His work not only advances medical technology but also improves the quality of life for patients with glaucoma.

Profile summary based on public USPTO records.